NCT07246317 2025-11-28Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast CancerTianjin Medical University Cancer Institute and HospitalPhase 2 Not yet recruiting188 enrolled